SCHEMBL28008554

SCHEMBL28008554

CCNC(CC(=O)OC)c1ccc(F)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.54
MAPT P10636 2/20 0.54
ALDH1A1 P00352 2/20 0.54
CYP2D6 P10635 4/20 0.43
KCNH2 Q12809 3/20 0.43
MMP1 P03956 1/20 0.43
MMP3 P08254 1/20 0.43
MMP9 P14780 1/20 0.43
MMP12 P39900 1/20 0.43
LMNA P02545 3/20 0.42
HPGD P15428 1/20 0.42
GAA P10253 1/20 0.42
FAAH O00519 1/20 0.41
CFD P00746 1/20 0.41
ROCK2 O75116 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20993600 1.00 HTT (0.54) HTTMAPTALDH1A1CYP2D6KCNH2
SCHEMBL16679992 0.84 FFAR1 (0.47) ALDH1A1LMNAHPGDGAANPSR1
SCHEMBL13802626 0.84 KCNA5 (0.47) ALDH1A1LMNAHPGDROCK2MEN1
SCHEMBL16679989 0.84 FFAR1 (0.47) ALDH1A1LMNAHPGDGAANPSR1
SCHEMBL16680217 0.84 ALDH1A1 (0.50) HTTMAPTALDH1A1CYP2D6KCNH2
SCHEMBL16680215 0.84 ALDH1A1 (0.50) HTTMAPTALDH1A1CYP2D6KCNH2
SCHEMBL29288506 0.83 FFAR1 (0.46) ALDH1A1LMNAHPGDGAANPSR1
SCHEMBL29288504 0.83 FFAR1 (0.46) ALDH1A1LMNAHPGDGAANPSR1
SCHEMBL22024055 0.81 HPGD (0.43) HTTMAPTALDH1A1CYP2D6KCNH2
SCHEMBL4855579 0.81 ALDH1A1 (0.48) HTTMAPTALDH1A1CYP2D6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104662015-B Complement pathway modulators and uses thereof 诺华股份有限公司 2017-03-29 CN disclosed
CN-104662015-A Complement pathway modulators and uses thereof NOVARTIS AG 2015-05-27 CN disclosed